Patrick Chalbos

Gene Expression Signature in Advanced Colorectal Cancer Patients Select Drugs and Response for the Use of Leucovorin, Fluorouracil, and Irinotecan

Maguy Del Rio, Franck Molina, Caroline Mollévi et al. · Journal of Clinical Oncology · 2007 · 209 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Impact of RNA degradation on gene expression profiles: Assessment of different methods to reliably determine RNA quality

Virginie Copois, Frédéric Bibeau, Caroline Mollévi et al. · Journal of Biotechnology · 2006 · 182 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Multicentre phase II study using increasing doses of irinotecan combined with a simplified LV5FU2 regimen in metastatic colorectal cancer

Jacqueline Duffour, Sophie Gourgou, Françoise Desseigne et al. · Cancer Chemotherapy and Pharmacology · 2006 · 20 citations

Medicine, Oncology, Pharmacology +12

Inter-observer agreement between dermatologists and oncologists in assessing dermatological toxicities in patients with metastatic colorectal cancer treated by cetuximab-based chemotherapies: A pilot comparative study

Jacqueline Duffour, Simon Thézenas, O. Dereure et al. · European Journal of Cancer · 2010 · 16 citations

Medicine, Dermatology, Oncology +17

<scp>GRECCAR</scp> 14 – a multicentric, randomized, phase <scp>II–III</scp> study evaluating the tailored management of locally advanced rectal carcinoma after a favourable response to induction chemotherapy: Study protocol

Philippe Rouanet, Florence Castan, Thibault Mazard et al. · Colorectal Disease · 2023 · 10 citations · Full text

Medicine, Oncology, Surgery +17